M. Inouye | Turku Hypertension Center

Latest

Role of Gut Microbiota in Statin-Associated New-Onset Diabetes-a Cross-Sectional and Prospective Analysis of the FINRISK 2002 Cohort
Author Correction: Greengenes2 unifies microbial data in a single reference tree
Microbiome-based risk prediction in incident heart failure: a community challenge
Greengenes2 unifies microbial data in a single reference tree
Gut microbiome and atrial fibrillation-results from a large population-based study
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
The gut microbiome is a significant risk factor for future chronic lung disease
Stroke genetics informs drug discovery and risk prediction across ancestries
Substantial Fat Loss in Physique Competitors Is Characterized by Increased Levels of Bile Acids, Very-Long Chain Fatty Acids, and Oxylipins
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Phylogeny-Aware Analysis of Metagenome Community Ecology Based on Matched Reference Genomes while Bypassing Taxonomy
A plasma metabolite score of three eicosanoids predicts incident type 2 diabetes: a prospective study in three independent cohorts
Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort
Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults
Efficient computation of Faith's phylogenetic diversity with applications in characterizing microbiomes
Associations of healthy food choices with gut microbiota profiles
Taxonomic signatures of cause-specific mortality risk in human gut microbiome
Links between gut microbiome composition and fatty liver disease in a large population sample
Eicosanoid Inflammatory Mediators Are Robustly Associated With Blood Pressure in the General Population
Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
Bacterial modification of the host glycosaminoglycan heparan sulfate modulates SARS-CoV-2 infectivity